There are 2934 resources available
Introduction
Presenter: Dirk Arnold
Session: ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard?
Resources:
Slides
Webcast
Is cytotoxic contamination an issue in wards?
Presenter: Klaus Meier
Session: ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard?
Resources:
Slides
Webcast
Perspective of the nurses
Presenter: Matthew Fowler
Session: ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard?
Resources:
Slides
Webcast
Presentation of preliminary results of MASHA project
Presenter: Ewelina Korczowska
Session: ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard?
Resources:
Slides
Webcast
Overview of the ESMO Precision Medicine Working Group accomplishments in 2018
Presenter: Fabrice André
Session: ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies
Resources:
Slides
Webcast
3502 - Randomised Efficacy and Safety Results For Atezolizumab (Atezo) + Bevacizumab (Bev) in Patients (pts) With Previously Untreated, Unresectable Hepatocellular Carcinoma (HCC)
Presenter: Michael Lee
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Neurological complications of immunotherapy
Presenter: Matthias Preusser
Session: CNS complications and management in systemic cancer patients
Resources:
Slides
Webcast
The value of PD-L1 as a biomarker beyond lung cancers
Presenter: Kevin Harrington
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Targeting the microenvironment
Presenter: Florent Petitprez
Session: Current markers in immunotherapy
Resources:
Slides
Webcast
Ex-vivo and 3D models: From mice to men
Presenter: Jos Jonkers
Session: Preclinical models and imaging to guide clinical therapy
Resources:
Slides
Webcast